Sunday, 16th June 2019
Cell Biology and Immunology

    Molecular pathophysiology of fibrosis


2017 07 13 Grupo Santiago Lamas 03 copia

 


Santiago Lamas

ASciStaff

APublications

 

Research summary:

Our laboratory is interested in the molecular mechanisms leading to fibrogenesis in human pathology. Fibrosis is the final common pathway for many organ diseases including diabetic kidney disease, liver cirrhosis, scleroderma, myocardial sclerosis and idiopathic or inflammatory-mediated pulmonary fibrosis. Evolving from a long-standing interest in the vascular wall and redox biology we have now focused our efforts on understanding how the process of fibrogenesis takes place with an emphasis on the role of microRNAs and their regulation by redox signals in processes such as epithelial to mesenchymal transition, TGF-b signaling and fibroblast to myofibroblast transformation. We employ cellular and animal models for lung, skin and kidney fibrosis. We plan to decipher not only the profile of microRNAs involved in fibrogenesis but also the link between the underlying metabolic cellular changes occurring in the fibrotic process and the triggering of specific redox responses leading to the expression of microRNAs relevant for fibrogenesis.

 

fig01





Animal model in lung fibrosis. Intratracheal administration of the antibiotic bleomycin to mice promotes the development of a progressive lung fibrosis phenotype characterized by the loss of the typical alveolar architecture of the lung and extensive accumulation of extracellular matrix components as assessed by histological examination with hematoxilin and eosin (H&E) and Masson´s trichome histological staining, respectively.

 

 


Recent publications:

  • Rodriguez P, Sassi Y, Troncone L, Benard L, Ishikawa K, Gordon RE, Lamas S, Laborda J, Hajjar RJ, Lebeche D. Deletion of delta-like 1 homologue accelerates fibroblast-myofibroblast differentiation and induces myocardial fibrosis. Eur Heart J. 2018 Apr. 13.                                                                                                                                                                           
  • Espinosa-Díez C, Miguel V, Vallejo S, Sánchez FJ, Sandoval E, Blanco E, Cannata P, Peiró C, Sánchez-Ferrer CF, Lamas S. Role of glutathione biosynthesis in endothelial dysfunction and fibrosis. Redox Biol. 2018 Apr. 14:88-99.
  • Miguel V, Cui JY, Daimiel L, Espinosa-Díez C, Fernández-Hernando C, Kavanagh TJ, Lamas SThe Role of MicroRNAs in Environmental Risk Factors, Noise-Induced Hearing Loss, and Mental Stress. Antioxid Redox Signal.  2018 Mar. 20;28(9):773-79
  • Espinosa-Díez C, Miguel V, Vallejo S, Sánchez FJ, Sandoval E, Blanco E, Cannata P, Peiró C, Sánchez-Ferrer CF, Lamas S. Role of glutathione biosynthesis in endothelial dysfunction and fibrosis. Redox Biol. 2017; 14:88-99.
  • Lamas S, Michel T. Introduction to Special Issue "Redox regulation of cardiovascular signaling in health and disease". Free Radic Biol Med. 2017; 109:1-3.
  • Daiber A, Steven S, Weber A, Shuvaev VV, Muzykantov VR, Laher I, Li H, Lamas S, Münzel T. Targeting vascular (endothelial) dysfunction2017; 174(12):1591-1619.
  • Miguel V, Busnadiego O, Fierro-Fernández M, Lamas S. Protective role for miR-9-5p in the fibrogenic transformation of human dermal fibroblasts. Fibrogenesis Tissue Repair. 2016; 9:7.
  • Fierro-Fernández M, Busnadiego  O, Sandoval P, Espinosa-Diez C, Blanco-Ruiz E, Rodriguez M, Pian H, Ramos R, López-Cabrera M, García-Bermejo ML, Lamas S. miR-9-5p suppresses pro-fibrogenic transformation of fibroblast  and prevents organ fibrosis by targeting NOX4 and  TGFBR2. Embo Reports 2015 16 (10):1358-77.
  • Sánchez-Gómez  FJ, Calvo  E, Bretón-Romero R, Fierro-Fernández M, Anilkumar N, Shah AM, Schröder K, Brandes RP, Vázquez J, Lamas S. NOX-4-dependent hydrogen peroxide  promotes shear stress-induced  SHP2 sulfenylation and eNOS activation. Free Radic Biol Med 2015, 89: 419-430
  • Espinosa-Díez C, Fierro-Fernández M, Sánchez-Gómez F, Rodríguez-Pascual F, Alique M, Ruiz Ortega M, Beraza N, Martínez-Chantar ML, Fernández-Hernando C, Lamas  S. Targeting  of Gamma-Glutamyl-Cysteine Ligase by miR-433 Reduces  Glutthione Biosynthesis  and Promotes  TGF-b-Dependent Fibrogenesis . Antioxid Redox Signal 2014
  • Bretón-Romero R, Acín-Perez R, Rodríguez-Pascual F, Martínez-Molledo M, Brandes RP, Rial E, Enríquez JA, Lamas S. Laminar shear stress regulates mitochondrial dynamics, bioenergetics responses and PRX3 activation in endothelial cells. Biochim Biophys Acta. 1843 (11): 2403-13.
  • Busnadiego O, Loureiro-Álvarez J, Sandoval P, Lagares D, Dotor J, Pérez-Lozano ML, López-Armada MJ, Lamas S, López-Cabrera M, Rodríguez-Pascual F. A Pathogenetic Role for Endothelin-1 in Peritoneal Dialysis-Associated Fibrosis. J Am Soc Nephrol. 2015, 26 (1): 173-82.
  • P Hernasanz Agustin; A Izquierdo Alvarez; F Javier Sánchez Gómez; E Ramos; T Villa Piña; S Lamas; A Bogdanova; A Martínez Ruiz. Acute hypoxia produces a superoxide burst in cells.Free Radical Biology & Medicine.  201471, pp. 146 -156.
  • R Bretón Romero; S Lamas. Hydrogen peroxide signaling in vascular endothelial cells.Redox Biol. 2014 2, pp. 529 - 534.
  • Sánchez-Gómez FJ,; Espinosa-Díez C,; Dubey M,; Dikshit M; Lamas S. S-glutathionylation: relevance in diabetes and potential role as a biomarker. Biol. Chem.
  • Olmos Y,; Sánchez-Gómez FJ,; Wild B; García-Quintans N,; Cabezudo S; Lamas S,; Monsalve M.SirT1 Regulation of Antioxidant Genes Is Dependent on the Formation of a FoxO3a/PGC-1# Complex. Antioxid Redox Signal, 2013 19(13): 1507-21.Martínez-Ruiz A; Araújo IM,; Izquierdo-Álvarez A,; Hernansanz-Agustín P; Lamas S,; Serrador JM. Specificity in S-Nitrosylation: A Short-Range Mechanism for NO Signaling?. Antioxid Redox Signal 
  • Laares, D., Busnadiego, O., García-Fernández, R.A., Lamas, S, and Rodríguez-Pascual, F. (2012) Adenoviral gene transfer of endothelin-1 in the lung induces pulmonary fibrosis through the activation of focal adhesion kinase. Am J Respir Cell Mol Biol. 47(6):834-42.
  • Martínez-Acedo, P., Núñez, E., Gómez, F.J., Moreno, M., Ramos, E., Izquierdo-Álvarez, A., Miró-Casas, E., Mesa, R., Rodríguez, P., Martínez-Ruiz, A., Dorado, D.G., Lamas, S, and Vázquez, J. (2012) A novel strategy for global analysis of the dynamic thiol redox proteome. Mol Cell Proteomics. 11(9):800-13.
  • Rodríguez-Pascual, F., Busnadiego, O., Lagares, D., and Lamas, S. (2011) Role of endothelin in the cardiovascular system. Pharmacol Res, 63(6):463-472.
  • Martínez-Ruiz, A., Cadenas, S., and Lamas, S. (2011) Nitric oxide signaling: classical, less classical, and nonclassical mechanisms. Free Radic Biol Med. 51(1):17-29.
  • Loureiro, J., Aguilera, A., Selgas, R., Sandoval, P., Albar-Vizcaíno, P., Pérez-Lozano, M.L., Ruiz-Carpio, V., Majano, P.L., Lamas, S., Rodríguez-Pascual, F., Borras-Cuesta, F., Dotor, J., and López-Cabrera, M. (2011) Blocking TGF-β1 protects the peritoneal membrane from dialysate-induced damage. J Am Soc Nephrol 22(9):1682-1695.

 


Doctoral Thesis:

M. Cristina  Espinosa Diez (2015). Papel de la g-glutamilcistein ligasa en modelos de daño vascular y fibrótico e implicación de miR-433 en la sintesis de  glutation. Director: Santiago Lamas

M. Ángeles Higueras López (2014). Fisiología y Fisiopatología de DLK-1 en el Endotelio Vascular. Universidad Complutense de Madrid. Directores: Santiago Lamas y Patricia Rodríguez

Rosa Bretón Romero (2013). Redox Signaling Responses to Laminar Shear Stress in vascular endothelial cells. Universidad Autónoma de Madrid. Director:Santiago Lamas

David Lagares Salto (2012) Implicaciones Fisiopatológicas y Terapeuticas del eje TGF-beta/ET-1 y la Quinasa de Adhesión Focal en los procesos Fibróticos. Universidad Autónoma de Madrid. Directores: Santiago Lamas Peláez y Fernando Rodríguez Pascual.


Patents:

European Application "Compounds for prevention and/or treatment of fibrotic diseases" Application No/Patent No 14382239.3-1401

International application  201031547 “Uso de Dlk1 como inhibidor de angiogénesis”, Dec 2011.


 Other activities:

.Organización de actividades I + D:

  • "Redox signaling and oxidative stress in health and disease IV Spanish and Portuguese meeting on free radicals" Valencia. Junio 2012
  • "Workshop on Gasotransmitters in health and disease" Madrid. Enero 2012
  • "XVII Simposio Internacional del Instituto "Reina Sofía" de Investigaciones Nefrológicas". Noviembre 2011
  • "Current Trends In Biomedicine. Molecular and Cellular Bases of Redox Signaling and Oxidative Stress: Implications in Biomedicine". Universidad Internacional de Andalucía. Simposium Internacional Baeza. Noviembre 2011
  • Curso de Verano "La fibrosis tisular en la enfermedad humana". Fundación General de la Universidad de Álcala de Henares. Septiembre 2012.

 

 Associate editor of the Redox Biology magazine  http://www.journals.elsevier.com/redox-biology/

 

NOTE! This site uses cookies and similar technologies.

If you not change browser settings, you agree to it. Learn more

I understand

COOKIES POLICY

What are cookies?

A cookie is a file that is downloaded to your computer when you access certain web pages. Cookies allow a web page, among other things, to store and retrieve information about the browsing habits of a user or their equipment and, depending on the information they contain and the way they use their equipment, they can be used to recognize the user.

Types of cookies

Classification of cookies is made according to a series of categories. However, it is necessary to take into account that the same cookie can be included in more than one category.

  1. Cookies according to the entity that manages them

    Depending on the entity that manages the computer or domain from which the cookies are sent and treat the data obtained, we can distinguish:

    • Own cookies: those that are sent to the user's terminal equipment from a computer or domain managed by the editor itself and from which the service requested by the user is provided.
    • Third party cookies: those that are sent to the user's terminal equipment from a computer or domain that is not managed by the publisher, but by another entity that processes the data obtained through the cookies. When cookies are installed from a computer or domain managed by the publisher itself, but the information collected through them is managed by a third party, they cannot be considered as own cookies.

  2. Cookies according to the period of time they remain activated

    Depending on the length of time that they remain activated in the terminal equipment, we can distinguish:

    • Session cookies: type of cookies designed to collect and store data while the user accesses a web page. They are usually used to store information that only is kept to provide the service requested by the user on a single occasion (e.g. a list of products purchased).
    • Persistent cookies: type of cookies in which the data is still stored in the terminal and can be accessed and processed during a period defined by the person responsible for the cookie, which can range from a few minutes to several years.

  3. Cookies according to their purpose

    Depending on the purpose for which the data obtained through cookies are processed, we can distinguish between:

    • Technical cookies: those that allow the user to navigate through a web page, platform or application and the use of different options or services that exist in it, such as controlling traffic and data communication, identifying the session, access to restricted access parts, remember the elements that make up an order, perform the purchase process of an order, make a registration or participation in an event, use security elements during navigation, store content for the broadcast videos or sound or share content through social networks.
    • Personalization cookies: those that allow the user to access the service with some predefined general characteristics based on a series of criteria in the user's terminal, such as the language, the type of browser through which the user accesses the service, the regional configuration from where you access the service, etc.
    • Analytical cookies: those that allow the person responsible for them to monitor and analyse the behaviour of the users of the websites to which they are linked. The information collected through this type of cookies is used in the measurement of the activity of the websites, applications or platforms, and for the elaboration of navigation profiles of the users of said sites, applications and platforms, in order to introduce improvements in the analysis of the data of use made by the users of the service.

Cookies used on our website

The CBMSO website uses Google Analytics. Google Analytics is a simple and easy to use tool that helps website owners to measure how users interact with the content of the site. You can consult more information about the cookies used by Google Analitycs in this link.

Acceptance of the Cookies Policy

The CBMSO assumes that you accept the use of cookies if you continue browsing, considering that it is a conscious and positive action from which the user's consent is inferred. In this regard, you are previously informed that such behaviour will be interpreted that you accept the installation and use of cookies.

Knowing this information, it is possible to carry out the following actions:

How to modify the configuration of cookies

Using your browser you can restrict, block or delete cookies from any web page. In each browser the process is different, here we show you links on this particular of the most used browsers: